214 related articles for article (PubMed ID: 31674043)
1. Risk factors for recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery: A retrospective review of 237 Asian patients.
Oh Y; Kim J; Zheng Z; Kim SK; Chung KY; Roh MR
J Dermatol; 2020 Jan; 47(1):72-77. PubMed ID: 31674043
[TBL] [Abstract][Full Text] [Related]
2. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study.
van Lee CB; Roorda BM; Wakkee M; Voorham Q; Mooyaart AL; de Vijlder HC; Nijsten T; van den Bos RR
Br J Dermatol; 2019 Aug; 181(2):338-343. PubMed ID: 30199574
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
[TBL] [Abstract][Full Text] [Related]
4. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma.
Pugliano-Mauro M; Goldman G
Dermatol Surg; 2010 Oct; 36(10):1544-53. PubMed ID: 21053415
[TBL] [Abstract][Full Text] [Related]
5. Mohs micrographic surgery local recurrences.
Hruza GJ
J Dermatol Surg Oncol; 1994 Sep; 20(9):573-7. PubMed ID: 8089356
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone.
Marrazzo G; Zitelli JA; Brodland D
J Am Acad Dermatol; 2019 Mar; 80(3):633-638. PubMed ID: 30244064
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Squamous Cell Carcinoma of the Lip Treated With Mohs Micrographic Surgery: A Retrospective Cohort Study.
Nadir U; Le K; Shi K; Srivastava D; Nijhawan RI
Dermatol Surg; 2023 Dec; 49(12):1108-1111. PubMed ID: 37910651
[TBL] [Abstract][Full Text] [Related]
10. Impact of Mohs Micrographic Surgery on Tumor Staging of Cutaneous Squamous Cell Carcinoma: A Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Guidelines.
Montuno MA; Brown B; Konda S; Motaparthi K
Dermatol Surg; 2018 Aug; 44(8):1057-1064. PubMed ID: 29746431
[TBL] [Abstract][Full Text] [Related]
11. Low local recurrence rates after Mohs micrographic surgery for cutaneous squamous cell carcinoma of the nail unit.
Veerabagu SA; Zhang J; Krausz AE; Fix WC; Cheng B; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Walker JL; Miller CJ
J Am Acad Dermatol; 2024 Apr; 90(4):832-833. PubMed ID: 38043591
[No Abstract] [Full Text] [Related]
12. Mohs micrographic surgery in rare cutaneous tumors: a retrospective study at a Brazilian tertiary university hospital.
Buffo TH; Stelini RF; Serrano JYM; Pontes LT; Magalhães RF; de Moraes AM
An Bras Dermatol; 2023; 98(1):36-46. PubMed ID: 36369200
[TBL] [Abstract][Full Text] [Related]
13. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.
Stevens JS; Murad F; Smile TD; O'Connor DM; Ilori E; Koyfman S; Vidimos A; Waldman AB; Ruiz ES
JAMA Dermatol; 2023 Jul; 159(7):728-735. PubMed ID: 37285135
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of basosquamous carcinoma after Mohs micrographic surgery.
Skaria AM
Dermatology; 2010; 221(4):352-5. PubMed ID: 20924160
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of intermediate-risk squamous cell carcinoma treated with Mohs micrographic surgery compared with wide local excision.
Udkoff J; Beal BT; Brodland DG; Knackstedt T
J Am Acad Dermatol; 2022 Feb; 86(2):303-311. PubMed ID: 34363906
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):253-60. PubMed ID: 16021120
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting outcomes of patients with high-risk squamous cell carcinoma treated with Mohs micrographic surgery.
Matsumoto A; Li JN; Matsumoto M; Pineider J; Nijhawan RI; Srivastava D
J Am Acad Dermatol; 2021 Sep; 85(3):588-595. PubMed ID: 33524409
[TBL] [Abstract][Full Text] [Related]
18. A review of Mohs micrographic surgery for skin cancer. Part 3: Squamous cell carcinoma.
Hunt WTN; Earp E; Brown AC; Veitch D; Wernham AGH
Clin Exp Dermatol; 2022 Oct; 47(10):1765-1773. PubMed ID: 35315541
[TBL] [Abstract][Full Text] [Related]
19. The Role of Mohs Surgery in Cutaneous Head and Neck Cancer.
Jefferson GD
Otolaryngol Clin North Am; 2021 Apr; 54(2):439-447. PubMed ID: 33602519
[TBL] [Abstract][Full Text] [Related]
20. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience.
Thomas CJ; Wood GC; Marks VJ
Dermatol Surg; 2007 Mar; 33(3):333-9. PubMed ID: 17338692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
